<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Administration of <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> in <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> (SAH) patients, misdiagnosed as <z:hpo ids='HP_0002076'>migraine</z:hpo> patients, may induce symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> with potentially dangerous consequences </plain></SENT>
<SENT sid="1" pm="."><plain>Over a 5-year period, we observed three patients with a 3-15-year history of <z:hpo ids='HP_0002076'>migraine</z:hpo>, who received <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients received 6 mg <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> subcutaneously on days 4 and 6, and one patient 3 x 100 mg <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> orally on day 1 after an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002315'>headache</z:hpo> episode </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> three cases, an alleviation of <z:hpo ids='HP_0002315'>headache</z:hpo> intensity from severe to moderate was observed </plain></SENT>
<SENT sid="4" pm="."><plain>When <z:hpo ids='HP_0002315'>headache</z:hpo> recurred and meningeal signs appeared, SAH was diagnosed by computed tomography in <z:hpo ids='HP_0000001'>all</z:hpo> three cases </plain></SENT>
<SENT sid="5" pm="."><plain>No neurological deficits occurred during the further course of the disease </plain></SENT>
<SENT sid="6" pm="."><plain>In both patients with a SAH caused by an <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, transcranial Doppler sonography demonstrated vasospasm of the basal cerebral arteries </plain></SENT>
<SENT sid="7" pm="."><plain>An antinociceptive effect of <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> can be observed in SAH patients in good clinical condition, which suggests a specific craniovascular antinociceptive action </plain></SENT>
<SENT sid="8" pm="."><plain>This may lead to misdiagnosis as <z:hpo ids='HP_0002076'>migraine</z:hpo> and delayed appropriate diagnosis and treatment </plain></SENT>
</text></document>